Yingjie Zhang

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 15

Top Topics

Structure Activity Relationship

Metastatic Renal Cell Carcinoma

Cell Proliferation

Vascular Endothelial Growth Factor

Top Venues

Journal of medicinal chemistry

Expert opinion on therapeutic patents

Molecules (Basel, Switzerland)

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Fengling Liu, Chunxi Liu, Qipeng Chai, Chunlong Zhao, Hongwei Meng, Xia Xue, Tso-Pang Yao, Yingjie Zhang
Discovery of the First Irreversible HDAC6 Isoform Selective Inhibitor with Potent Anti-Multiple Myeloma Activity. Journal of medicinal chemistry (2023)
Chunlong Zhao, Yu Zhang, Jin'ge Zhang, Shunda Li, Mengyang Liu, Yinping Geng, Fengling Liu, Qipeng Chai, Hongwei Meng, Mengzhe Li, Jintao Li, Yi-Chao Zheng, Yingjie Zhang
Discovery of Novel Fedratinib-Based HDAC/JAK/BRD4 Triple Inhibitors with Remarkable Antitumor Activity against Triple Negative Breast Cancer. Journal of medicinal chemistry (2023)
Qifu Xu, Guozhen Zhang, Qian Liu, Shunda Li, Yingjie Zhang
Inhibitors of the GTPase KRAS G12C in cancer: a patent review (2019-2021). Expert opinion on therapeutic patents 32 (5) (2022)
Jiangying Cao, Chunlong Zhao, Hang Dong, Qifu Xu, Yingjie Zhang
Development of pyrazoline-based derivatives as aminopeptidase N inhibitors to overcome cancer invasion and metastasis. RSC advances 11 (35) (2021)
Xuewu Liang, Shuai Tang, Xuyi Liu, Yingluo Liu, Qifu Xu, Xiaomin Wang, Abdusaid Saidahmatov, Chunpu Li, Jiang Wang, Yu Zhou, Yingjie Zhang, Meiyu Geng, Min Huang, Hong Liu
Discovery of Novel Pyrrolo[2,3-d]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors. Journal of medicinal chemistry (2021)
Qian Liu, Hang Dong, Wei Zhao, Guozhen Zhang, Shunda Li, Qifu Xu, Yingjie Zhang
Design, Synthesis, and Biological Evaluation of APN and AKT Dual-Target Inhibitors. ACS medicinal chemistry letters 12 (12) (2021)
Jiangying Cao, Wei Zhao, Chunlong Zhao, Qian Liu, Shunda Li, Guozhen Zhang, C James Chou, Yingjie Zhang
Development of a Bestatin-SAHA Hybrid with Dual Inhibitory Activity against APN and HDAC. Molecules (Basel, Switzerland) 25 (21) (2020)
Chunlong Zhao, Hang Dong, Qifu Xu, Yingjie Zhang
Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present). Expert opinion on therapeutic patents 30 (4) (2020)
Yugang Yan, Qifu Xu, Chunlong Zhao, Hang Dong, Wenfang Xu, Yingjie Zhang
In vivo pharmacokinetic study and oral glucose tolerance test of sulfoxide analogs of GPR40 agonist TAK-875. Drug development research 81 (6) (2020)
Hang Dong, Hao Yin, Chunlong Zhao, Jiangying Cao, Wenfang Xu, Yingjie Zhang
Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors. Molecules (Basel, Switzerland) 24 (13) (2019)
Xuewu Liang, Jie Zang, Xiaoyang Li, Shuai Tang, Min Huang, Meiyu Geng, C James Chou, Chunpu Li, Yichun Cao, Wenfang Xu, Hong Liu, Yingjie Zhang
Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies. Journal of medicinal chemistry 62 (8) (2019)
Jie Zang, Xuewu Liang, Yongxue Huang, Yuping Jia, Xiaoyang Li, Wenfang Xu, C James Chou, Yingjie Zhang
Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously. Journal of medicinal chemistry 61 (12) (2018)
Xiaoyang Li, Yuri K Peterson, Elizabeth S Inks, Richard A Himes, Jiaying Li, Yingjie Zhang, Xiujie Kong, C James Chou
Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status. Journal of medicinal chemistry 61 (6) (2018)
Jiangying Cao, Jie Zang, Chunhua Ma, Xiaoguang Li, Jinning Hou, Jin Li, Yongxue Huang, Wenfang Xu, Binghe Wang, Yingjie Zhang
Design, Synthesis, and Biological Evaluation of Pyrazoline-Based Hydroxamic Acid Derivatives as Aminopeptidase N (APN) Inhibitors. ChemMedChem 13 (5) (2018)
Jingyao Li, Xiaoyang Li, Xue Wang, Jinning Hou, Jie Zang, Shuai Gao, Wenfang Xu, Yingjie Zhang
PXD101 analogs with L-phenylglycine-containing branched cap as histone deacetylase inhibitors. Chemical biology & drug design 88 (4) (2016)